HeraMED Ltd. Statistics
HeraMED Ltd. (1I4) Stock Statistics & Valuation Metrics
Total Valuation
HeraMED Ltd. has a market cap or net worth of EUR 24.97M. The enterprise value is EUR 39.94M.
- Market Cap
- EUR 24.97M
- Enterprise Value
- EUR 39.94M
Share Statistics
HeraMED Ltd. has 1,158,636,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,158,636,600
- Owned by Insiders
- 0.54%
- Owned by Institutions
- ―
Financial Efficiency
HeraMED Ltd.’s return on equity (ROE) is -4.44 and return on invested capital (ROIC) is -370.62%.
- Return on Equity (ROE)
- -4.44
- Return on Assets (ROA)
- -2.77
- Return on Invested Capital (ROIC)
- -370.62%
- Return on Capital Employed (ROCE)
- -3.95
- Revenue Per Employee
- 32.63K
- Profits Per Employee
- ―
- Employee Count
- 6
- Asset Turnover
- 0.20
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of HeraMED Ltd. is -10.78. HeraMED Ltd.’s PEG ratio is -0.21.
- PE Ratio
- -10.78
- PS Ratio
- 267.51
- PB Ratio
- 15.69
- Price to FCF
- -12.60
- Price to Operating Cash Flow
- -12.60
- PEG Ratio
- -0.21
Income Statement
In the last 12 months, HeraMED Ltd. had revenue of 195.77K and earned ― in profits. Earnings per share was -0.00.
- Revenue
- 195.77K
- Gross Profit
- 99.78K
- Operating Income
- -2.66M
- Pretax Income
- ―
- Net Income
- ―
- EBITDA
- -2.56M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -2.18M and capital expenditures -3, giving a free cash flow of -2.18M billion.
- Operating Cash Flow
- -2.18M
- Free Cash Flow
- -2.18M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
HeraMED Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.93%
- Earnings Yield
- -8.58%
Stock Price Statistics
- Beta
- 1.01
- 52-Week Price Change
- -25.93%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- 45.90
- Average Volume (3m)
- 37.81K
Important Dates
HeraMED Ltd. upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
HeraMED Ltd. as a current ratio of 3.00, with Debt / Equity ratio of 45.45%
- Current Ratio
- 3.00
- Quick Ratio
- 3.00
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.25
- Interest Coverage Ratio
- -946.83
Taxes
In the past 12 months, HeraMED Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
HeraMED Ltd. EV to EBITDA ratio is -11.50, with an EV/FCF ratio of -11.67.
- EV to Sales
- 247.86
- EV to EBITDA
- -11.50
- EV to Free Cash Flow
- -11.67
- EV to Operating Cash Flow
- -11.67
Balance Sheet
HeraMED Ltd. has EUR 2.03M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 2.03M billion.
- Cash & Marketable Securities
- EUR 2.03M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 2.03M
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- EUR 0.00
Margins
Gross margin is 92.92%, with operating margin of -2162.24%, and net profit margin of -2295.93%.
- Gross Margin
- 92.92%
- Operating Margin
- -2162.24%
- Pretax Margin
- -2295.93%
- Net Profit Margin
- -2295.93%
- EBITDA Margin
- -2155.16%
- EBIT Margin
- -2162.24%
Analyst Forecast
The average price target for HeraMED Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -55.21%
- EPS Growth Forecast
- 41.94%
Scores
- Smart Score
- 2
- AI Score
- ―
